RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/14623330http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/14623330http://www.w3.org/2000/01/rdf-schema#comment"We recently showed that alpha4beta1 integrin induces B-cell chronic lymphocytic leukemia (B-CLL) cell resistance to fludarabine-induced apoptosis via upregulation of Bcl-xL. We have now studied whether p53 was involved in this response. Cells from five B-CLL patients with wild-type p53 determined by DNA sequencing, or from the EHEB cell line, cultured on the alpha4beta1 ligand H/89 during fludarabine treatment, showed significantly higher viability (Pxsd:string
http://purl.uniprot.org/citations/14623330http://purl.org/dc/terms/identifier"doi:10.1016/j.bbrc.2003.10.054"xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/author"Silva A."xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/author"Garcia-Pardo A."xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/author"Casanova B."xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/author"Cantero E."xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/author"Garcia-Marco J."xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/author"Hernandez del Cerro M."xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/author"de la Fuente M.T."xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/date"2003"xsd:gYear
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/name"Biochem Biophys Res Commun"xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/pages"708-712"xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/title"Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine."xsd:string
http://purl.uniprot.org/citations/14623330http://purl.uniprot.org/core/volume"311"xsd:string
http://purl.uniprot.org/citations/14623330http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/14623330
http://purl.uniprot.org/citations/14623330http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/14623330
http://purl.uniprot.org/uniprot/#_A0A087WXZ1-mappedCitation-14623330http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14623330
http://purl.uniprot.org/uniprot/#_A0A087X1Q1-mappedCitation-14623330http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14623330
http://purl.uniprot.org/uniprot/#_A0A0C4KX50-mappedCitation-14623330http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14623330
http://purl.uniprot.org/uniprot/#_A0A023IP86-mappedCitation-14623330http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14623330
http://purl.uniprot.org/uniprot/#_A0A218MJE5-mappedCitation-14623330http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14623330
http://purl.uniprot.org/uniprot/#_A0A087WT22-mappedCitation-14623330http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14623330
http://purl.uniprot.org/uniprot/#_A0A0A0U7X4-mappedCitation-14623330http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14623330
http://purl.uniprot.org/uniprot/#_A0A346XLN8-mappedCitation-14623330http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/14623330